Showing results (221-230 of 353) with videos related to
Sort By:
Pageof 36
Clinical Trials (London, England)|November 12, 2005
Issues in regulatory guidelines for data monitoring committeesDavid DeMets, Robert Califf, Dennis Dixon, et al.BMJ Open|December 18, 2023
Comparing the long-term outcomes in chronic coronary syndrome patients with prior ST-segment and non-ST-segment elevation myocardial infarction: findings from the TIGRIS registrySibi N Krishnamurthy, Stuart Pocock, Prashant Kaul, et al.Circulation. Heart Failure|March 8, 2021
Synergistic Impact of Systolic Blood Pressure and Perfusion Status on Mortality in Acute Heart FailureXavier Rossello, Héctor Bueno, Víctor Gil, et al.Circulation|February 10, 2026
Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL TrialMahesh V Madhavan, John Gregson, Bjorn Redfors, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|June 13, 2019
Development of a Yoga-Based Cardiac Rehabilitation (Yoga-CaRe) Programme for Secondary Prevention of Myocardial InfarctionKaushik Chattopadhyay, Ambalam M Chandrasekaran, Pradeep A Praveen, et al.Royal Society Open Science|August 4, 2020
Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemicJulian Peto, James Carpenter, George Davey Smith, et al.BMJ Open|August 17, 2025
Rationale and design of SCOPE trial: a prospective, multicentre, open-label, randomised controlled trial to evaluate the overall efficacy and safety of a short-term anticoagulation strategy versus conventional single antiplatelet therapy in patients with severe aortic stenosis without indications for anticoagulation or dual antiplatelet therapy post-transcatheter aortic valve replacementYunfeng Yan, Yang Li, Ran Liu, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 4, 2024
One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trialSigrid Sandner, Mario Gaudino, Bjorn Redfors, et al.Journal of the American College of Cardiology|November 22, 2023
Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 YearsGuiomar Mendieta, Stuart Pocock, Virginia Mass, et al.The Lancet. Diabetes & Endocrinology|November 20, 2020
Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trialDarren K McGuire, Bernard Zinman, Silvio E Inzucchi, et al.Pageof 36